Acutus Medical Inc Cash Flow Conversion Efficiency
Acutus Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Acutus Medical Inc (AFIB) has a cash flow conversion efficiency ratio of 0.350x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.06 Million) by net assets ($-11.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Acutus Medical Inc (2018–2024)
Cash flow conversion efficiency of Acutus Medical Inc from 2018 to 2024. This chart illustrates how Acutus Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AFIB stock price and chart for real-time trading data and today's change.
Acutus Medical Inc Cash Flow Conversion Ratio Explained
Acutus Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Acutus Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Acutus Medical Inc ranked by their cash flow conversion efficiency. Also see market value of Acutus Medical Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Insplorion AB
ST:INSP
|
-0.139x |
|
Teras Resources Inc
V:TRA
|
0.129x |
|
Change Agents Corporation
NASDAQ:CHGA
|
-0.069x |
|
Geneuro SA
PA:GNRO
|
0.393x |
|
Urbanimmersive Inc
V:UI
|
-0.002x |
|
Olenox Industries Inc.
NASDAQ:OLOX
|
-0.026x |
|
NeutriSci International Inc
V:NU
|
0.006x |
|
Forward Water Technologies Corp
V:FWTC
|
-0.052x |
Annual Cash Flow Conversion Efficiency for Acutus Medical Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Acutus Medical Inc from 2018 to 2024. Review Acutus Medical Inc (AFIB) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-11.59 Million | $-31.66 Million | 2.731x | -96.20% |
| 2023-12-31 | $-879.00K | $-63.12 Million | 71.807x | +6435.10% |
| 2022-12-31 | $75.02 Million | $-85.03 Million | -1.133x | -20.22% |
| 2021-12-31 | $105.73 Million | $-99.68 Million | -0.943x | -40.13% |
| 2020-12-31 | $126.58 Million | $-85.17 Million | -0.673x | -371.38% |
| 2019-12-31 | $-225.81 Million | $-55.99 Million | 0.248x | -3.25% |
| 2018-12-31 | $-131.82 Million | $-33.78 Million | 0.256x | -- |
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well a… Read more